338
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Development and evaluation of puerarin-loaded controlled release nanostructured lipid carries by central composite design

, , , , , & show all
Pages 113-125 | Received 29 May 2020, Accepted 15 Nov 2020, Published online: 06 Jan 2021

References

  • Yeung DK , Leung SW , Xu YC , et al. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol. 2006;552(1-3):105–111.
  • Zhang L. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine. Drug Deliv. 2019;26(1):860–869.
  • Zhang B , Li M , Wang Q , et al. Exploring adverse effects of puerarin on catalase by multiple spectroscopic investigations and docking studies in vitro . J Biochem Mol Toxicol. 2019;33(5):e22296–22302.
  • Wong KH , Li GQ , Li KM , et al. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol. 2011;134(3):584–607.
  • Wang N , Zhang Y , Wu L , et al. Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. Neuropharmacology. 2014;79:282–289.
  • Wu X-D , Wang C , Zhang Z-Y , et al. Puerarin attenuates cerebral damage by improving cerebral microcirculation in spontaneously hypertensive rats. Evid Based Complement Alternat Med. 2014;2014:1–501.
  • Tan C , Wang A , Liu C , et al. Puerarin improves vascular insulin resistance and cardiovascular remodeling in salt-sensitive hypertension. Am J Chin Med. 2017;45(6):1169–1184.
  • Wang S , Shi X-L , Feng M , et al. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition . Int Immunopharmacol. 2016;38:238–245.
  • Xu L , Zheng N , He Q , et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect. Phytomedicine. 2013;20(13):1172–1179.
  • Hu Y-X , Yu C-H , Wu F , et al. Antihepatofibrotic effects of aqueous extract of prunella vulgaris on carbon tetrachloride-induced hepatic fibrosis in rats. Planta Med. 2016;82(1-2):97–105.
  • Liu Y , Tang Q , Shao S , et al. Lyophilized powder of catalpol and puerarin protected cerebral vessels from ischemia by its anti-apoptosis on endothelial cells. Int J Biol Sci. 2017;13(3):327–338.
  • Li Z , Shangguan Z , Liu Y , et al. Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway. J Mol Endocrinol. 2014;53(1):71–79.
  • Zhong Y , Zhang X , Cai X , et al. Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. PLoS One. 2014;9(1):e85690.
  • Wang J-W , Wang H-D , Cong Z-X , et al. Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. J Surg Res. 2014;186(1):328–337.
  • Mahdy HM , Mohamed MR , Emam MA , et al. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. Can J Physiol Pharmacol. 2014;92(3):252–258.
  • Zhao L , Wang Y , Liu J , et al. Protective effects of genistein and puerarin against chronic alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms. J Agric Food Chem. 2016;64(38):7291–7297.
  • Wang S , Yang F , Shang L , et al. Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis. Phytother Res. 2019;33(9):2347–2359.
  • Liu R , Xing D , Lu H , et al. Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats. Am J Chin Med. 2006;34(06):1037–1045.
  • Lv YQ , Tan TW. Modeling and prediction of the mixed-mode retention mechanisms for puerarin and its analogues on n-octylamine modified poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate) monoliths. Process Biochem. 2009;44(11):1225–1230.
  • Zhang Z , Chen Y , Deng J , et al. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO: preparation, characterization and in vivo studies . Int J Pharm. 2014;465(1-2):306–316.
  • Zhou H , Wan J , Wu L , et al. A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS. PLoS One. 2013;8(12):e84530.
  • Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc. 2006;65(3):278–290.
  • Arteel GE. Alcohol-induced oxidative stress in the liver: in vivo measurements. Methods Mol Biol. 2008;447:185–197.
  • Vidali M , Stewart SF , Albano E. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol Med. 2008;14(2):63–71.
  • Frazier TH , Stocker AM , Kershner NA , Marsano LS , et al. Treatment of alcoholic liver disease. Therap Adv Gastroenterol. 2011;4(1):63–81.
  • Hu S , Shen G , Zhao W , et al. Paeonol, the main active principles of Paeoniamoutan, ameliorates alcoholic steatohepatitis in mice. J Ethnopharmacol. 2010;128(1):100–106.
  • Qu ZW , Wen CY , Wang AP , et al. Protective effect of puerarin on rats with alcoholic hepatitis. WCJD. 2009;17(7):657–661.
  • Hyder MAH. Nanotechnology and Environment: Potential Applications and Environmental Implications of Nanotechnology [master’s thesis]. Hamburg: Hamburg University of Technology; German, 2003.
  • Müller RH. Cytotoxicity of magnetite loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles (SLN). Int J Pharm. 1996;138(1):85–94.
  • Yang SC , Lu LF , Cai Y , et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release. 1999;59(3):299–307.
  • Wissing SA , Kayser O , Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56(9):1257–1272.
  • Müller RH , Radtke M , Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242(1-2):121–128.
  • Hu F-Q , Jiang S-P , Du Y-Z , et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerf. 2005;45(3-4):167–173.
  • Lawrence MJ , Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2012;64:175–193.
  • L, Shinde R , B, Jindal A , V, Devarajan P. Microemulsions and nanoemulsions for targeted drug delivery to the brain. Cnano. 2011;7:119–133.
  • Kalaitzis P , El-Zein Z. Olive oil authentication, traceability and adulteration detection using DNA-based approaches. Lipid Technol. 2016;28(10-11):173–176.
  • Ciafardini G , Zullo BA. Virgin olive oil yeasts: a review. Food Microbiol. 2018;70:245–253.
  • Kamel AE , Fadel M , Louis D. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. Int J Nanomed. 2019; 14:5073–5085.
  • Bombardelli E , Cristoni A , Morazzoni P. Phytosomes in functional cosmetics. Fitoterapia. 1994;65:387–401.
  • Yu F , Li Y , Chen Q , et al. Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. Eur J Pharm Biopharm. 2016;103:136–148.
  • Ge L , He X , Zhang Y , et al. A dabigatran etexilate phospholipid complex nanoemulsion system for further oral bioavailability by reducing drug-leakage in the gastrointestinal tract. Nanomed Nanotechnol Biol Med. 2018;14(4):1455–1464.
  • Saba K , Sanjula B , Javed A. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Drug Dev Ind Pharm. 2016;42(2):209–220.
  • Liu X , Zhi H , Du F , et al. A HPLC-UV method for the determination of puerarin in rat plasma after intravenous administration of PEGylated puerarin conjugate. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(31):3297–3302.
  • Landfester K. Miniemulsions for nanoparticle synthesis. In Antonietti M , ed. Colloid chemistry II. Berlin, Heidelberg: Springer; 2003.
  • How CW , Rasedee A , Abbasalipourkabir R. Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil, and polysorbate 80. IEEE Trans Nanobiosci. 2013;12(2):72–78.
  • Jores K , Mehnert W , Drechsler M , et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 2004;95(2):217–227.
  • Gonzalez-Mira E , Egea MA , Souto EB , et al. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology. 2011;22(4):045101.
  • Li X , Wang D , Zhang J , et al. Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers. J Pharm Pharmacol. 2009;61(11):1485–1492.
  • Ghasemian E , Vatanara A , Najafabadi AR , et al. Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design. Daru. 2013;21(1):68–78.
  • Pinto F , Barros D , Reis C , et al. Optimization of nanostructured lipid carriers loaded with retinoids by central composite design. J Mol Liq. 2019;293:111468.
  • Keshri L , Pathak K. Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis. Pharm Dev Technol. 2013;18(3):634–644.
  • Zheng M , Falkeborg M , Zheng Y , et al. Formulation and characterization of nanostructured lipid carriers containing a mixed lipids core. Colloids Surf A Physicochem Eng Asp. 2013; 430:76–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.